Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry‐Based Case–Control Study
Journal of Diabetes · 2025
DOI: 10.1111/1753-0407.70076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, 2025. Verfasst von Asger Ahlmann Bech und 4 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center North Denmark, Aalborg University Hospital, Gistrup, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Diabetes Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish Diabetes and Endocrine Academy, Novo Nordisk Foundation, Novo Nordisk Fonden.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
This study aimed to investigate the association between cardiovascular risk factors and major adverse cardiovascular events (MACE) in people with type 2 diabetes, while assessing potential changes over time.
Methods
Utilizing data from Danish registries, this study identified people with type 2 diabetes between 2002 and 2021 ( n = 372 328) and subdivided them into two 10‐year time periods: TP1: 2002–2011 and TP2: 2012–2021, and further categorized into cases and controls. Cases were defined as having suffered a first‐time three‐point MACE ( n TP1 = 12 713, n TP2 = 8981) and matched 1:1 with controls on age, sex, and type 2 diabetes duration. Exposures were preselected diabetes complications and comorbidities.
Results
Fewer were affected by MACE during TP2 compared to TP1 ( p < 0.001). Diabetes complications associated with MACE were nephropathy (OR TP1 = 1.54, 95% CI 1.30–1.83, OR TP2 = 1.47, 95% CI 1.20–1.79), neuropathy (OR TP1 = 2.02, 95% CI 1.84–2.21 OR TP2 = 1.58, 95% CI 1.44–1.73) and retinopathy (OR TP1 = 1.10, 95% CI 0.98–1.23, OR TP2 = 1.38, 95% CI 1.17–1.63). Comorbidities associated with MACE included hypertension (OR TP1 = 1.30, 95% CI 1.22–1.38 OR TP2 = 1.31, 95% CI 1.22–1.41), atrial flutter or fibrillation (OR TP1 = 1.46, 95% CI 1.35–1.58, OR TP2 = 1.37, 95% CI 1.26–1.50), heart failure (OR TP1 = 1.53, 95% CI 1.401.67‐, OR TP2 = 1.37, 95% CI 1.23–1.54) and hypercholesterolemia (OR TP1 = 1.13, 95% CI 1.07–1.20, OR TP2 = 1.02, 95% CI 0.96–1.10). Hypercholesterolemia ( p = 0.038) and neuropathy ( p = 0.038) exhibited a significant decrease in association with MACE between the time periods.
Conclusions
The prevalence of first‐time MACE decreased over time, despite a relatively stable prevalence of type 2 diabetes. Several diabetes‐related complications and comorbidities were significantly associated with MACE. The associations of neuropathy and hypercholesterolemia with MACE lessened over time, suggesting potential improvements in risk management or treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Steno Diabetes Center North Denmark, Aalborg University Hospital, Gistrup, Denmark.
- Department of Clinical Medicine and Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
ORCID-Profile: Asger Ahlmann Bech
Förderung
- Danish Diabetes and Endocrine Academy
- Novo Nordisk Foundation
- Novo Nordisk Fonden
Zitieren
APA
Bech, A. A., Madsen, M. D., Kvist, A. V., Vestergaard, P., & Rasmussen, N. H. (2025). Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry‐Based Case–Control Study. Journal of Diabetes. https://doi.org/10.1111/1753-0407.70076
Vancouver
Bech AA, Madsen MD, Kvist AV, Vestergaard P, Rasmussen NH. Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry‐Based Case–Control Study. Journal of Diabetes. 2025. doi:10.1111/1753-0407.70076
BibTeX
@article{Bech2025,
author = {Bech, Asger Ahlmann and Madsen, Mia Daugaard and Kvist, Annika Vestergaard and Vestergaard, Peter and Rasmussen, Nicklas Højgaard-Hessellund},
title = {Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry‐Based Case–Control Study},
journal = {Journal of Diabetes},
year = {2025},
doi = {10.1111/1753-0407.70076}
}
EUVIMED